Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach (2023)
Attributed to:
Big Data for Complex Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s40545-023-00590-9
Publication URI: http://dx.doi.org/10.1186/s40545-023-00590-9
Type: Journal Article/Review
Parent Publication: Journal of Pharmaceutical Policy and Practice
Issue: 1